MyChesCo on MSN9h
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular TherapyNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its financial results for 2024, alongside major ...
To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback